New Vaccine Panel Members Impact COVID Shot Guidance
Updated CDC vaccine advisory panel membership may influence COVID vaccine recommendations and patient treatment plans for physicians.
Executive Brief
- The News: 5 new members join CDC vaccine advisory panel
- Clinical Win: 12-member panel influences Vaccines for Children program
- Target Specialty: Pediatricians and epidemiologists benefit from new policies
Key Data at a Glance
Number of New Members: 5
Total Committee Members: 12
Meeting Location: Atlanta
Meeting Dates: Thursday and Friday
Topics for Consideration: COVID-19 booster shot, hepatitis B vaccine
Vaccines for Children Program: Free vaccines determined by committee recommendations
New Vaccine Panel Members Impact COVID Shot Guidance
Just days before vaccine advisers to the Centers for Disease Control and Prevention meet to weigh who should get COVID vaccines this season, Health Secretary Robert F. Kennedy Jr. has selected five more members to the committee he purged of Biden administration appointees in June.
The new members of the influential Advisory Committee on Immunization Practices are:
Hilary Blackburn, a pharmacist at AscensionRx, who also hosts a podcast,
Dr. Kirk Milhoan, a pediatric cardiologist and an affiliate of the Independent Medical Alliance,
Dr. Evelyn Griffin, an ob/gyn and functional medicine practitioner,
Dr. Raymond Pollak, a semi-retired transplant surgeon, and
Catherine Stein, an epidemiology professor at Case Western Reserve University, who has claimed the government overstated COVID risks.
"The new ACIP members bring a wealth of real-world public health experience to the job of making immunization recommendations," said Jim O'Neill, Deputy Secretary of Health and Human Services and Acting Director of the CDC in a media statement. "We are grateful for their service in helping restore the public confidence in vaccines that was lost during the Biden era."
The advisory group – now numbering 12 members – makes recommendations that help determine which vaccines are offered free through the Vaccines for Children program, and what health insurers typically cover. They also influence state and local laws around vaccine requirements.
The appointments expand the committee just before it meets this week in Atlanta. On Thursday and Friday, the members will be considering policies such as who should get the fall COVID-19 booster shot, and whether all babies should get the hepatitis B vaccine at birth.
Short list of members leaked in early September
The new members were among seven that appeared on a list that was first reported by the "Inside Medicine" newsletter on Sept. 3. Two others who were named then — Dr. Joseph Fraiman, an emergency medical physician, and Dr. John Gaitanis, a pediatric neurologist at Hasbro Children's Hospital in Rhode Island — were not appointed to the committee by HHS.
NPR reached out to each of the new members of the committee earlier this month, when their names first appeared in media reports. Only one responded.
Dr. Raymond Pollak, a semi-retired transplant surgeon, was still in the midst of the vetting process on Sept. 5. "I think I'd be an ideal choice for a committee like this," he told NPR. "I have expertise in clinical trial management and ethics, and my background in transplant biology allows me to understand the science of what is being proposed."
Pollak says he had not paid much attention to ACIP before he joined the committee, but he sees having non-vaccine experts on the panel as a plus. "I think it's a value to have broad representation of the community at large, both with and without the necessary expertise in order to formulate policy that makes sense to everybody," he says.
And while Pollack considers COVID vaccines "safe to administer and provided a benefit in that it kept down the severity of the illness and prevented hospitalization," he says the vaccine rollout was "poorly managed," contributing to hysteria and conspiracy theories that the government covered up harms and injuries related to the vaccine. "The notion that the government tried to 'cover it up' is false," Pollak says. "All of the information on adverse effects is readily available in the medical literature. The problem is it tends to stay within the profession and doesn't get disseminated widely amongst the public."
Kennedy's imprint on vaccine panel grows
The new members join the seven others Kennedy named to the panel in June, replacements he handpicked after firing all 17 of the panel's previously seated members. The replacements, who met for the first time at the CDC in June, include Dr. Robert Malone, who has spread misinformation about COVID and opposed vaccine mandates, and Retsef Levi, an MIT professor of operations management who gained prominence during the pandemic for criticizing COVID vaccines.
The members Kennedy fired had been chosen for their medical expertise and understanding of vaccine policy, and had been formally vetted to ensure that they would not directly financially benefit from any ACIP votes. They had been serving in overlapping rotations over several years to ensure continuity of expertise and process.
"There are large gaps in the new ACIP's composition in terms of their missing expertise on vaccinology, their missing expertise on primary care, their missing expertise on cost effectiveness and clinical trials," says Noel Brewer, a former ACIP member who had served on the committee for a year before being dismissed by Kennedy in June. "These are folks who fundamentally do not understand vaccines in a deep way. I wouldn't take medical advice from them, and I certainly don't think they should be setting policy for the United States."
Clinical Perspective — Dr. Kavya Sharma, Cardiology
Workflow: As I prepare for patient consultations, I'm considering the updated Advisory Committee on Immunization Practices (ACIP) roster, which now includes 12 members, including Dr. Kirk Milhoan, a pediatric cardiologist, and Catherine Stein, an epidemiology professor. The new members' expertise will inform my discussions with patients about vaccine recommendations. With the ACIP meeting this week, I'm anticipating updated guidance on fall COVID-19 booster shots and hepatitis B vaccine administration.
Economics: The article doesn't address cost directly, but I'm aware that the Vaccines for Children program and health insurers typically cover vaccines recommended by the ACIP. As a doctor, I'd like to see more data on the economic impact of vaccine recommendations, but for now, I'm focused on staying up-to-date on the latest guidance from the ACIP.
Patient Outcomes: I'm interested in the potential patient benefits of the updated ACIP recommendations, particularly regarding the fall COVID-19 booster shot and hepatitis B vaccine administration. While the article doesn't provide specific outcome data, I'm looking forward to reviewing the committee's findings and incorporating them into my patient care decisions, potentially influencing policies such as vaccine requirements and insurance coverage.
Transparency & Corrections
HCP Connect is funded by Stravent LLC and maintains editorial independence from advertisers and pharmaceutical companies. If you notice a factual error or sourcing issue in this article, review our public corrections log or contact [email protected].
Drug Update Briefing